CO5070713A1 - Procedimiento para la preparacion de acidos hidroxamicos - Google Patents
Procedimiento para la preparacion de acidos hidroxamicosInfo
- Publication number
- CO5070713A1 CO5070713A1 CO99021089A CO99021089A CO5070713A1 CO 5070713 A1 CO5070713 A1 CO 5070713A1 CO 99021089 A CO99021089 A CO 99021089A CO 99021089 A CO99021089 A CO 99021089A CO 5070713 A1 CO5070713 A1 CO 5070713A1
- Authority
- CO
- Colombia
- Prior art keywords
- aryl
- heteroaryl
- alkyl
- alkoxy
- oxyheteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
- C07C239/08—Hydroxylamino compounds or their ethers or esters
- C07C239/14—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Un procedimiento para la preparación de una molécula que contiene un grupo ácido hidroxámico que comprende la reacción de hidroxilamina, o una sal de la misma, con haluro de sililo en presencia de una base, seguido de la reacción con una molécula que contiene un haluro de ácido carboxílico seguido de la reacción con un ácido, con la condición de que la molécula que contiene un haluro de ácido carboxílico no contenga un grupo hidroxi, una amina primaria, una amina secundaria o un grupo tiol.La presente invención se refiere a un procedimiento para la preparación de ácidos hidroxámidos a partir de intermedios ácido hidroxílico, en el que el intermedio de ácido carboxílico no posee sustituyentes eractivos, tales como grupos hidroxi o amino. Un procedimiento para la preparación de un compuesto de fórmula Z es ANDgt;CH2 o ANDgt;NR1 ; Q es alquilo (C1-C6 ), arilo (C6- C10 ), heteroarilo (C2 -C9 ), oxiarilo (C6 -C10 )alquilo (C1 -C6 ), oxiarilo (C6 -C10 )arilo (C6 -C10 )oxiarilo (C6 -C10 ) heteroarilo (C2 -C9 ), arilo (C6 -C10 ), alquilo (C1 -C6 ), aril (C6 -C10 ), arilo (C6 -C10 ), aril (C6 -C10 ), heteroarilo (C2 -C9 ), aril (C6 -C10 ), aril (C6 -C10 ), alquilo (C1 -C6 ).aril (C6-C10) aril (C6-C10) arilo (C1-C10) , aril (C6-C10) aril (C6-C10) heteroarilo (C2-C9), heteroaril (C2-C9) alquilo (C1-C6) , heteroaril (C2-C9) arilo (C6-C10), heteroarilo (C2-C9) heteroarilo (C2-C9), arilo (C6-C10) alcoxi (C1-C6) alquilo (C1- C6) , arilo (C6-C10) alcoxi (C1-C6) arilo (C6-C10) , aril (C6-C10) alcoxi (C1-C6) heteroarilo (C2-C9) , oxiheteroarilo (C2-C9) alquilo (C1-C6) , oxiheteroarilo (C2-C9) arilo (C6-C10), oxiheteroarilo (C2-C9) heteroarilo (C2-C9), heteroaril (C2-C9) alcoxi (C1-C6) alquilo (C1-C6) , heteroaril (C2-C9) alcoxi (C1-C6) arilo (C6-C10) o heteroaril (C2- C9) alcoxi (C1-C6) heteroarilo (C2 - C9); en la que cada radical arilo (C6-C10) o heteroarilo (C2-C9) de dichos arilo (C6-C10), heteroarilo (C2-C9), oxiarilo (C6-C10) alquilo (C1-C6), oxiarilo (C6-C10) arilo (C6-C10), oxiarilo (C6-C10) heteroarilo (C2-C9), arilo (C6-C10) alquilo (C1-C6), aril (C6-C10) arilo (C6-C10) , aril (C6-C10) heteroarilo (C2-C9), aril (C6-C10) aril (C6-C10) alquilo (C1-C6) , aril (C6-C10) aril (C6-C10) arilo (C6-C10), aril (C6-C10) aril (C6-C10) heteroarilo (C2-C9), heteroaril (C2-C9) alquilo (C1-C6), heteroaril (C2-C9) arilo (C6-C10), heteroarilo (C2-C9) heteroarilo (C2-C9), arilo (C6-C10) alcoxi (C1-C6) alquilo (C1-C6), arilo (C6-C10) alcoxi (C1-C6) arilo (C6-C10) , arilo (C6-C10) alcoxi (C1-C6) heteroarilo (C2-C9), oxiheteroarilo (C2-C9) alquilo (C1-C6), oxiheteroarilo (C2-C9) arilo (C6-C10), oxiheterarilo (C2-C9) heteroarilo (C2-C9), heteroaril (C2-C9) alcoxi (C1-C6) alquilo (C1-C6), heteroaril (C2-C9) alcoxi (C1-C6) arilo (C6-C10) o heteroaril (C2-C9) alcoxi (C1-C6) heteroarilo (C2-C9) está opcionalmente sustituido sobre cualquiera de los átomos de carbono del anillo capaces de formar un enlace adicional mediante uno o más sustituyentes por anillo independientemente seleccionado entre fluoro, cloro, bromo, alquilo (C1-C6), alcoxi (C1-C6), ...
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8136598P | 1998-04-10 | 1998-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5070713A1 true CO5070713A1 (es) | 2001-08-28 |
Family
ID=22163686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO99021089A CO5070713A1 (es) | 1998-04-10 | 1999-04-09 | Procedimiento para la preparacion de acidos hidroxamicos |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US6288246B1 (es) |
| EP (1) | EP0949244A3 (es) |
| JP (1) | JPH11343277A (es) |
| KR (1) | KR100329902B1 (es) |
| CN (1) | CN1232023A (es) |
| AP (1) | AP1203A (es) |
| AR (1) | AR018180A1 (es) |
| AU (1) | AU747629B2 (es) |
| BG (1) | BG64154B1 (es) |
| BR (1) | BR9901089A (es) |
| CA (1) | CA2268680A1 (es) |
| CO (1) | CO5070713A1 (es) |
| DZ (1) | DZ2757A1 (es) |
| EA (1) | EA002777B1 (es) |
| EG (1) | EG22263A (es) |
| GT (1) | GT199900046A (es) |
| HR (1) | HRP990105A2 (es) |
| HU (1) | HUP9901041A3 (es) |
| ID (1) | ID23337A (es) |
| IL (1) | IL129328A0 (es) |
| IN (1) | IN192342B (es) |
| IS (1) | IS5019A (es) |
| MA (1) | MA24831A1 (es) |
| NO (1) | NO991672L (es) |
| NZ (1) | NZ335104A (es) |
| OA (1) | OA11031A (es) |
| PA (1) | PA8469301A1 (es) |
| PE (1) | PE20000418A1 (es) |
| PL (1) | PL332450A1 (es) |
| SG (1) | SG125880A1 (es) |
| SK (1) | SK43699A3 (es) |
| TN (1) | TNSN99052A1 (es) |
| TR (1) | TR199900755A3 (es) |
| TW (1) | TW448147B (es) |
| UA (1) | UA57750C2 (es) |
| UY (1) | UY25460A1 (es) |
| YU (1) | YU18199A (es) |
| ZA (1) | ZA992631B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9918684D0 (en) | 1999-08-09 | 1999-10-13 | Novartis Ag | Organic compounds |
| US6458822B2 (en) | 2000-03-13 | 2002-10-01 | Pfizer Inc. | 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases |
| GB0103303D0 (en) | 2001-02-09 | 2001-03-28 | Novartis Ag | Organic compounds |
| WO2004106319A1 (en) * | 2003-05-30 | 2004-12-09 | Pfizer Products Inc. | Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide |
| AU2003264355A1 (en) * | 2003-08-29 | 2005-03-29 | Basf Aktiengesellschaft | Process for production of o-substituted hydroxylamines |
| EP3082526A4 (en) | 2013-12-18 | 2017-07-05 | Brita LP | Lid for filter-as-you-pour container system |
| TW202237119A (zh) | 2020-12-10 | 2022-10-01 | 美商住友製藥腫瘤公司 | Ａｌｋ﹘５抑制劑和彼之用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA794723B (en) | 1978-09-11 | 1980-08-27 | Univ Miami | Anti-hypertensive agents |
| GB9000725D0 (en) | 1990-01-12 | 1990-03-14 | Pfizer Ltd | Therapeutic agents |
| US5552419A (en) * | 1993-01-06 | 1996-09-03 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamic acids |
| US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
| SK21499A3 (en) | 1996-08-23 | 2000-05-16 | Pfizer | Arylsulfonylamino hydroxamic acid derivatives |
| DE69817801T2 (de) | 1997-02-03 | 2004-03-11 | Pfizer Products Inc., Groton | Arylsulfonylhydroxamsäurederivate |
| ATE217863T1 (de) | 1997-08-08 | 2002-06-15 | Pfizer Prod Inc | Arylsulfonylaminohydroxamsäurederivate |
| TR200000368T2 (tr) | 1997-08-08 | 2000-07-21 | Pfizer Products Inc. | Ariloksiariarilsülfonilamino hidroksamik asit türevleri. |
| PA8469401A1 (es) | 1998-04-10 | 2000-05-24 | Pfizer Prod Inc | Derivados biciclicos del acido hidroxamico |
-
1999
- 1999-03-19 PA PA19998469301A patent/PA8469301A1/es unknown
- 1999-03-25 GT GT199900046A patent/GT199900046A/es unknown
- 1999-03-26 EP EP99302343A patent/EP0949244A3/en not_active Withdrawn
- 1999-04-01 SK SK436-99A patent/SK43699A3/sk unknown
- 1999-04-01 OA OA9900074A patent/OA11031A/en unknown
- 1999-04-05 IL IL12932899A patent/IL129328A0/xx unknown
- 1999-04-06 IS IS5019A patent/IS5019A/is unknown
- 1999-04-06 IN IN512DE1999 patent/IN192342B/en unknown
- 1999-04-06 PE PE1999000278A patent/PE20000418A1/es not_active Application Discontinuation
- 1999-04-06 TW TW088105453A patent/TW448147B/zh active
- 1999-04-07 DZ DZ990058A patent/DZ2757A1/xx active
- 1999-04-07 TN TNTNSN99052A patent/TNSN99052A1/fr unknown
- 1999-04-07 MA MA25526A patent/MA24831A1/fr unknown
- 1999-04-07 UY UY25460A patent/UY25460A1/es not_active Application Discontinuation
- 1999-04-07 CN CN99104834A patent/CN1232023A/zh active Pending
- 1999-04-07 US US09/287,508 patent/US6288246B1/en not_active Expired - Fee Related
- 1999-04-07 ID IDP990307D patent/ID23337A/id unknown
- 1999-04-08 SG SG1999001650A patent/SG125880A1/en unknown
- 1999-04-08 YU YU18199A patent/YU18199A/sh unknown
- 1999-04-08 TR TR1999/00755A patent/TR199900755A3/tr unknown
- 1999-04-08 AR ARP990101598A patent/AR018180A1/es not_active Application Discontinuation
- 1999-04-08 UA UA99041999A patent/UA57750C2/uk unknown
- 1999-04-08 KR KR1019990012326A patent/KR100329902B1/ko not_active IP Right Cessation
- 1999-04-08 CA CA002268680A patent/CA2268680A1/en not_active Abandoned
- 1999-04-08 AP APAP/P/1999/001503A patent/AP1203A/en active
- 1999-04-08 EG EG37399A patent/EG22263A/xx active
- 1999-04-09 JP JP11103156A patent/JPH11343277A/ja active Pending
- 1999-04-09 HR HR60/081,365A patent/HRP990105A2/hr not_active Application Discontinuation
- 1999-04-09 BR BR9901089-5A patent/BR9901089A/pt not_active IP Right Cessation
- 1999-04-09 HU HU9901041A patent/HUP9901041A3/hu unknown
- 1999-04-09 CO CO99021089A patent/CO5070713A1/es unknown
- 1999-04-09 PL PL99332450A patent/PL332450A1/xx not_active Application Discontinuation
- 1999-04-09 AU AU23690/99A patent/AU747629B2/en not_active Ceased
- 1999-04-09 NO NO991672A patent/NO991672L/no not_active Application Discontinuation
- 1999-04-09 BG BG103319A patent/BG64154B1/bg unknown
- 1999-04-09 EA EA199900284A patent/EA002777B1/ru not_active IP Right Cessation
- 1999-04-09 ZA ZA9902631A patent/ZA992631B/xx unknown
- 1999-04-09 NZ NZ335104A patent/NZ335104A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2406722C2 (ru) | Соли бис-(тиогидразидамида) для лечения рака | |
| AR057032A1 (es) | Tigeciclina y metodos de preparacion | |
| ES2582471T3 (es) | Inhibidores polibásicos de la bomba de flujo de salida bacteriana que contienen boro y usos terapéuticos de los mismos | |
| ES2788673T3 (es) | Proceso de preparación de N-boc bifenil alaninol | |
| AR060489A1 (es) | Derivados del acido benzoazepin - oxi- acetico como agonistas de ppar - delta usados para aumentar hdl- c, reducir ldl-c y reducir colesterol | |
| PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
| AR044694A1 (es) | Proceso y compuestos intermedios para la preparacion de (1r, 2s,5s) - 3 azabiciclo [3,1,0] hexano-2- carboxamida, n- [3- amino-1- (ciclobutilmetil) - 2, 3 - dioxopropil] -3- [ (2s) - 2 - [[ [ 1,1- dimetiletil] amino] carbonilamino] -3,3-dimetil -1- oxobutil]-6,6 dimetilo | |
| AR054881A1 (es) | Inhibidores macrociclicos de la replicacion del virus de la hepatitis c, un proceso para su preparacion, una composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento para el tratamiento de la hepatitis c | |
| BRPI0612926B8 (pt) | compostos fluorados de 4-(2-amino-1-hidroxietila)fenol como agonistas de receptores b2 adrenérgicos, composição farmacêutica, combinação e uso de um composto | |
| ES2568878T3 (es) | Inversión del bloqueo neuromuscular inducido por fármacos usando contenedores moleculares de cucurbit[n]urilo novedosos | |
| AR039150A1 (es) | Piridinoilpiperidinas como agonistas de 5-ht1f | |
| BR112012007305A2 (pt) | maitansinoides e o uso dos ditos maitansinoides para preparar conjugados com um anticorpo. | |
| BRPI0516911A (pt) | método para a preparação de um composto e composto de anilina | |
| AR057383A1 (es) | Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto | |
| AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
| AR057380A1 (es) | Compuestos quimicos derivados de 2-azetidinona y uso terapeutico de los mismos | |
| AR115561A1 (es) | Aditivos para combustible de amonio cuaternario | |
| GT200300010A (es) | Esteres hidroxamato del acido n-(4-fenil sustituido)-antranilico | |
| AR051373A1 (es) | Procedimiento para la preparacion de analogos aciclicos de nucleotidos de fosfonatos | |
| EA201291370A1 (ru) | Способ получения плеуромутилинов | |
| BR112018076686A2 (pt) | composição para a remoção de composto que contém enxofre | |
| CO5070713A1 (es) | Procedimiento para la preparacion de acidos hidroxamicos | |
| AR070885A1 (es) | Compuestos de azaindol para el tratamiento de trastornos del sistema nervioso central | |
| AR049668A1 (es) | Proceso quimico para preparar esteres de 4,4 - difluorometil - 3 - oxo - butanoico por reaccion entre una amida y un ester. | |
| AR091075A1 (es) | Proceso para preparar derivados monociclicos de heteroaril-cicloalquil-diamina |